Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05494762 |
| Title | Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | BeiGene |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010 | United States | Details | |
| Yale University, Yale Cancer Center | New Haven | Connecticut | 06520 | United States | Details | |
| Tennessee Oncology, Pllc Nashville | Nashville | Tennessee | 37203 | United States | Details | |
| Blacktown Cancer and Haematology Centre | Blacktown | New South Wales | 2148 | Australia | Details | |
| Ashford Cancer Centre Research | Kurralta Park | South Australia | 5037 | Australia | Details | |
| Monash Health | Clayton | Victoria | 3168 | Australia | Details | |
| Peter Maccallum Cancer Centre | Melbourne | Victoria | 3000 | Australia | Details | |
| The Alfred Hospital | Melbourne | Victoria | 3004 | Australia | Details |